Technology areas: Biotechnology & Pharmaceuticals • Transportation, E-Commerce & Mechanical Systems • Medical Devices & Mechanical Engineering
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 9 patents granted in the last 365 days
Jinan University currently has 4 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 4 distinct examiners and 4 distinct art units. DURDEN, RICHARD KYLE, is the busiest examiner for this portfolio, currently managing 1 busiest examiner pending action. Each of the 4 pending actions is assigned to a different examiner and a different art unit.
The distribution of 4 pending office actions among 4 distinct examiners and 4 distinct art units indicates a highly diversified prosecution effort. This suggests that the university's research in Biotechnology & Pharmaceuticals covers a wide range of specialized sub-fields. DURDEN, RICHARD KYLE, as the busiest examiner with 1 action, represents only a fraction of the total active workload. Because each action is in a different art unit, practitioners must tailor their arguments to 4 different sets of technical standards and examiner preferences. This lack of examiner overlap means that the progress of any single application does not directly impact the others. The presence of 4 pending office actions shows an active pipeline of academic research being moved toward patent protection. Managing 4 distinct examiners requires a coordinated strategy to ensure consistency across the university's various pharmaceutical and biotechnological claims. This decentralized approach ensures that the portfolio is not dependent on a single point of review.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (25%) |
| §103 only | 1 (25%) |
| Multi-statute (no §101) | 2 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DURDEN, RICHARD KYLE | 1 | 60.9% | +29.0% |
| BAUER, BRIANNA LEE | 1 | 66.7% | +0.0% |
| LOZA, JANICE JOMARIE | 1 | 11.8% | +33.3% |
| ELENISTE, PIERRE PAUL | 1 | 35.4% | +31.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18537839 | METHOD AND SYSTEM FOR ESCROW-FREE ATOMIC CROSS-CHAIN SWAP WITH RECIPIENT'S CONFIRMATION | LOZA, JANICE JOMARIE | 176d overdue |
| 18666700 | FLEXIBLE HOSE MATERIAL AND A WATER PIPE MADE OF THE FLEXIBLE HOSE MATERIAL | DURDEN, RICHARD KYLE | — |
| 18702818 | PHARMACEUTICAL COMPOSITION COMPRISING C21 STEROID SAPONIN AND USE THEREOF | BAUER, BRIANNA LEE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18537839 | METHOD AND SYSTEM FOR ESCROW-FREE ATOMIC CROSS-CHAIN SWAP WITH RECIPIENT'S CONFIRMATION | LOZA, JANICE JOMARIE | 176d overdue |
| 18666700 | FLEXIBLE HOSE MATERIAL AND A WATER PIPE MADE OF THE FLEXIBLE HOSE MATERIAL | DURDEN, RICHARD KYLE | — |
| 17737988 | INDAZOLE COMPOUNDS AND THEIR PHARMACEUTICAL COMPOSITIONS | ELENISTE, PIERRE PAUL | — |
| Art Unit | Apps |
|---|---|
| 3753 | 1 |
| 1623 | 1 |
| 3698 | 1 |
| 1622 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18666700 | FLEXIBLE HOSE MATERIAL AND A WATER PIPE MADE OF THE FLEXIBLE HOSE MATERIAL | DURDEN, RICHARD KYLE | 3753 | §103§112 | Non-Final OA | — | Pending | May 16, 2024 |
| 18702818 | PHARMACEUTICAL COMPOSITION COMPRISING C21 STEROID SAPONIN AND USE THEREOF | BAUER, BRIANNA LEE | 1623 | §102§103 | Non-Final OA | — | Pending | Apr 19, 2024 |
| 18537839 | METHOD AND SYSTEM FOR ESCROW-FREE ATOMIC CROSS-CHAIN SWAP WITH RECIPIENT'S CONFIRMATION | LOZA, JANICE JOMARIE | 3698 | §101§103§112Other | Final Rejection | 176d overdue | Pending | Dec 13, 2023 |
| 17737988 | INDAZOLE COMPOUNDS AND THEIR PHARMACEUTICAL COMPOSITIONS | ELENISTE, PIERRE PAUL | 1622 | §103 | Final Rejection | — | Pending | May 05, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialJinan University has 4 pending office actions as of October 2026, spread across 4 art units and 4 examiners.
Richard Kyle Durden has the most, with 1 of Jinan University's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
